Third project calls for deCODE to conduct screening of its Fragments of Life library against an InterMune target.
deCODE biostructures initiated a third research project with InterMune. Under the research agreement, deCODE biostructures will conduct screening of its Fragments of Life™ library against an InterMune target. The research fee and milestone-based research collaboration will utilize deCODE’s proprietary Fragments of Life technology and crystallographic methods to enable identification of new chemical intellectual property for small molecule inhibitors of InterMune’s drug target.
